Get the Stockscreener App
7.09
8.24%
0.54
After Hours:
7.08
-0.010
-0.14%
Bolt Biotherapeutics Inc stock is traded at $7.09, with a volume of 19,408.
It is up +8.24% in the last 24 hours and up +33.02% over the past month.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
See More
Previous Close:
$6.55
Open:
$6.74
24h Volume:
19,408
Relative Volume:
0.66
Market Cap:
$13.61M
Revenue:
$4.17M
Net Income/Loss:
$-50.71M
P/E Ratio:
-0.5262
EPS:
-13.474
Net Cash Flow:
$-51.40M
1W Performance:
+13.62%
1M Performance:
+33.02%
6M Performance:
+12.18%
1Y Performance:
-30.94%
1-Day Range:
$6.65
$7.09
1-Week Range:
$6.1448
$7.09
52-Week Range:
$4.41
$10.50
Bolt Biotherapeutics Inc Stock (BOLT) Company Profile
Name
Bolt Biotherapeutics Inc
Sector
Industry
Phone
650-665-9295
Address
900 CHESAPEAKE DRIVE, REDWOOD CITY
Compare BOLT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BOLT
Bolt Biotherapeutics Inc
|
7.09 | 12.57M | 4.17M | -50.71M | -51.40M | -13.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Bolt Biotherapeutics Inc Stock (BOLT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-25 | Resumed | H.C. Wainwright | Buy |
| Jan-06-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-02-21 | Initiated | Guggenheim | Buy |
| Mar-02-21 | Initiated | Morgan Stanley | Overweight |
| Mar-02-21 | Initiated | SVB Leerink | Outperform |
| Mar-02-21 | Initiated | Stifel | Buy |
View All
Bolt Biotherapeutics Inc Stock (BOLT) Latest News
Insider Trends: What is the long term forecast for Bolt Biotherapeutics Inc stockJuly 2025 Chart Watch & AI Powered Market Entry Ideas - baoquankhu1.vn
Risk Recap: Can ETRACS 2x Leveraged US Value Factor TR ETN maintain sales growth2025 Trade Ideas & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Nasdaq Moves: Whats the outlook for Bolt Biotherapeutics Incs sector2025 Valuation Update & Technical Confirmation Trade Alerts - baoquankhu1.vn
Risks Report: What are the analyst revisions for Bolt Biotherapeutics IncIs ZKIN stock a good investment in YEARMarket Growth Summary & Weekly Return Optimization Plans - baoquankhu1.vn
Is Bolt Biotherapeutics Inc. a speculative investmentWeekly Earnings Recap & Proven Capital Preservation Methods - bollywoodhelpline.com
Is Bolt Biotherapeutics Inc a top pick in the sectorJuly 2025 Chart Watch & AI Based Trade Execution Alerts - baoquankhu1.vn
Weekly Recap: Can Quince Therapeutics Inc sustain its profitabilityJuly 2025 Price Swings & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Portfolio Shifts: Is Bolt Biotherapeutics Inc a top pick in the sectorJuly 2025 Movers & Long Hold Capital Preservation Tips - baoquankhu1.vn
Aug Final Week: Does ELAB stock reflect fundamentalsBull Run & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Bolt appoints Olta Andoni as SVP of legal and people to support platform expansion across checkout, identity, and payments - marketscreener.com
Layoff Tracker: Lyra Shutters, EMD Serono Downsizes - BioSpace
Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Short Interest Down 83.8% in December - Defense World
Aug Analyst Calls: What momentum indicators show for Bolt Biotherapeutics Inc stockQuarterly Portfolio Report & AI Forecasted Stock Moves - Bộ Nội Vụ
Entry Recap: Will Bolt Biotherapeutics Inc. (6LP0) stock enhance shareholder valueMarket Volume Report & Advanced Technical Signal Analysis - Bộ Nội Vụ
Portfolio Shifts: Is Bolt Biotherapeutics Inc undervalued by DCF analysisJuly 2025 Chart Watch & Reliable Breakout Forecasts - baoquankhu1.vn
Analyst Calls: Why Bolt Biotherapeutics Inc 6LP0 stock fits value portfoliosJuly 2025 Price Swings & Verified High Yield Trade Plans - moha.gov.vn
Can Bolt Biotherapeutics Inc. stock continue upward trendWeekly Investment Summary & Real-Time Market Sentiment Alerts - Улправда
Will Bolt Biotherapeutics Inc. stock outperform tech sector in 2025Contrarian Investment Ideas & High Return Trading Strategies - bollywoodhelpline.com
Why Bolt Biotherapeutics Inc. (6LP0) stock fits value portfoliosPortfolio Profit Report & AI Driven Stock Movement Reports - ulpravda.ru
Can Bolt Biotherapeutics Inc. (6LP0) stock hold up in economic slowdownExit Point & Consistent Income Trade Ideas - ulpravda.ru
How Bolt Biotherapeutics Inc. stock performs after earningsJuly 2025 Pullbacks & Free Expert Approved Momentum Trade Ideas - Улправда
Will Eversource Energy (NWJ) stock maintain strong growthWeekly Stock Report & AI Optimized Trading Strategy Guides - Улправда
How supply shortages influence Bolt Biotherapeutics Inc. (6LP0) stockDividend Hike & Stepwise Entry/Exit Trade Alerts - ulpravda.ru
Will Bolt Biotherapeutics Inc. stock reach all time highs in 2025Earnings Overview Summary & Pattern Based Trade Signal System - Улправда
ulpravda ru > 2026> Is QLYS stock a buy on dipsEarnings Miss & Fast Gain Swing Alerts - Улправда
Should I hold or sell Contineum Therapeutics Inc. stock in 2025July 2025 Closing Moves & Safe Entry Momentum Tips - Улправда
Fundamentals Check: Can Bolt Biotherapeutics Inc. stock continue upward trend2025 Breakouts & Breakdowns & Verified Short-Term Plans - Улправда
Earnings Beat: Will Bolt Biotherapeutics Inc. stock reach all time highs in 2025Trade Entry Report & Free Technical Confirmation Trade Alerts - Улправда
Is Bolt Biotherapeutics Inc. stock supported by innovation pipelineJuly 2025 Update & Weekly High Return Opportunities - ulpravda.ru
SMA structure is bullish with the price reclaiming key MAs.Day Trading Setups & Affordable Market Strategies - ulpravda.ru
Bolt Biotherapeutics (BOLT) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Is Bolt Biotherapeutics Inc. (6LP0) stock a fit for income portfolios2026 world cup usa national team quarterfinals goalkeepers set piece tactics expert forecast expert opinion - ulpravda.ru
Published on: 2026-01-06 14:34:38 - ulpravda.ru
Will Bolt Biotherapeutics Inc. (6LP0) stock enhance shareholder value2026 world cup usa national team semifinals defensive leaders set piece tactics knockout prediction breakdown - ulpravda.ru
Street Watch: Why Bolt Biotherapeutics Inc. stock could rally in 2025Trade Ideas & Short-Term Trading Alerts - Bộ Nội Vụ
Performance Recap: Will STEM stock test record highs in 2025Earnings Miss & Technical Analysis for Trade Confirmation - moha.gov.vn
Bajaj Electricals Limited Attempts Reversal From Key SupportProtective Put Strategies & Diversify Intelligently to Avoid Big Hits - bollywoodhelpline.com
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Bloom Dekor Limited (526225) Announces Strategic ShiftMoving Average Crossovers & Free Stop-Loss Planning for Your Portfolio - bollywoodhelpline.com
BOLT SEC FilingsBolt Biotherapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Bolt Biotherapeutics (NASDAQ:BOLT) Share Price Passes Below Two Hundred Day Moving Average – What’s Next? - Defense World
Why Bolt Biotherapeutics Inc. stock could rally in 2025Trade Analysis Report & Free Safe Entry Trade Signal Reports - Улправда
Published on: 2025-12-21 07:10:36 - Улправда
What analyst consensus says on Bolt Biotherapeutics Inc. stockDay Trade & High Accuracy Buy Signal Tips - Улправда
Published on: 2025-12-20 08:01:52 - Улправда
Will Bolt Biotherapeutics Inc. stock rally after Fed decisionsDollar Strength & Verified High Yield Trade Plans - Улправда
Will Bolt Biotherapeutics Inc. stock beat EPS estimatesGDP Growth & Risk Controlled Swing Alerts - DonanımHaber
Shorts Report: Is Bolt Biotherapeutics Inc. stock vulnerable to regulatory risksMarket Risk Report & Daily Oversold Stock Bounce Ideas - DonanımHaber
Is Bolt Biotherapeutics Inc. (6LP0) stock undervalued at current price2025 Pullback Review & Entry and Exit Point Strategies - Улправда
Published on: 2025-12-19 09:21:25 - Улправда
Aug Intraday: Is Bolt Biotherapeutics Inc. stock trading at a premium valuation2025 Risk Factors & Precise Trade Entry Recommendations - Улправда
Bolt Biotherapeutics Inc Stock (BOLT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.09%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):